Debut Plus

₹2,826.8

▼ -23.66 -0.83%

As of 23 Oct 2026 · delayed

NSE Listed

Gland Pharma Limited (GLAND)

Volume: 4,23,057Avg Vol 1W: 4,59,445.2Avg Vol 1M: 4,05,014.952W Range:₹1,573.6₹3,171
NSE BSE www.glandpharma.com AI Report
Key Ratios
Checked 16h ago
Market Cap₹46,645 Cr
Current Price₹2,826.8
Previous Close₹2,850.46
High / Low (52w)₹3,171 / ₹1,573.6
Volume4,23,057
Avg Vol (1W)4,59,445.2
Avg Vol (1M)4,05,014.9
Stock P/E40.71
Book Value₹627.71
Dividend Yield71%
ROE9.92%
ROA9.02%
Revenue (TTM)₹6,747 Cr
Revenue Growth-0.8%
Profit Margin16.78%
Total Debt₹78 Cr
Shares Outstanding17 Cr
Face Value₹1
EPS (TTM)₹69.44
P/B4.5
Debt / Equity0.03
50 DMA₹2,933.47
200 DMA₹2,265.88
Day change-0.83%
Price Chart
₹2,826.8▲ 47.38% · 1Y
₹3151₹159787.6L
2025-10-27
2026-10-23

20-day avg volume: 4.1L shares

Pros
  • Pays a dividend yield of 71.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 23% YoY.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹1,406 Cr₹1,384 Cr₹1,425 Cr₹1,506 Cr₹1,487 Cr₹1,695 Cr₹1,743 Cr₹1,800 Cr
EBITDA₹263 Cr₹322 Cr₹296 Cr₹324 Cr₹292 Cr₹390 Cr₹516 Cr₹439 Cr
Net Profit₹164 Cr₹205 Cr₹187 Cr₹215 Cr₹184 Cr₹261 Cr₹367 Cr₹317 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹5,830 Cr₹1,030 Cr₹1,039 Cr₹1,074 Cr₹1,178 Cr₹1,262 Cr₹6,747 Cr₹1,287 Cr
EBITDA₹1,105 Cr₹395 Cr₹370 Cr₹413 Cr₹437 Cr₹571 Cr₹1,522 Cr₹488 Cr
Net Profit₹699 Cr₹290 Cr₹269 Cr₹302 Cr₹308 Cr₹420 Cr₹1,027 Cr₹364 Cr
EPS42.4—————62.28—
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹4,086 Cr₹6,496 Cr₹7,834 Cr₹8,778 Cr₹10,661 Cr₹11,225 Cr₹12,511 Cr
Total Liabilities₹440 Cr₹593 Cr₹676 Cr₹819 Cr₹1,937 Cr₹2,074 Cr₹2,153 Cr
Equity₹3,646 Cr₹5,903 Cr₹7,158 Cr₹7,959 Cr₹8,724 Cr₹9,151 Cr₹10,358 Cr
Total Debt———————
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹945 Cr₹916 Cr₹1,197 Cr₹675 Cr₹1,303 Cr₹1,269 Cr₹1,487 Cr
Investing₹-766 Cr₹-1,524 Cr₹-1,003 Cr₹1,208 Cr₹-1,757 Cr₹1,705 Cr₹138 Cr
Financing₹-7 Cr₹1,238 Cr₹35 Cr₹15 Cr₹-799 Cr₹-433 Cr₹-417 Cr
Free Cash Flow₹945 Cr₹916 Cr₹1,197 Cr₹675 Cr₹1,303 Cr₹1,269 Cr₹1,487 Cr
Shareholding
Promoter 45.75% Institutions 43.58% Public 10.67%
Efficiency & Working Capital
ROCE14%
Interest Coverage45
Dividend Payout—
Debtor Days107 d
Inventory Days99 d
Payable Days47 d
Cash Conversion Cycle159 d
Working Capital Days206 d
Shareholding Details

As of 2026-09-30

Promoter45.8%
FII10.4%
DII33.2%
Institutions43.6%
Public10.7%
Promoter Pledge0%
No. of Shareholders1,25,667
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters57.9%57.9%51.8%51.8%51.8%51.8%51.8%51.8%51.8%51.8%51.8%45.8%
FIIs4%3.6%6.9%4.5%5%6.9%7.4%7.9%7.6%7.3%8.7%10.4%
DIIs23.1%25.2%32.8%35.4%34.8%33.3%32.9%32.6%33%33.4%30.4%33.2%
Public15%13.3%8.5%8.3%8.3%8%7.9%7.6%7.6%7.5%9.1%10.7%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,36,0211,22,3751,22,6651,22,3581,21,0751,13,7881,10,67197,15194,57891,5001,08,2661,25,667
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Fosun Pharma Industrial Pte. LtdShareholding of Promoter and Promoter Group45.8%7.55 Cr
Hdfc Mutual Fund - Hdfc Mid-cap FundPublic Shareholding5.6%92,42,690
Nippon Life India Trustee Ltd- A/c Nippon India Growth Mid Cap FundPublic Shareholding4.9%80,40,644
Sbi Large & Midcap FundPublic Shareholding3.2%52,73,017
Mirae Asset Large & Midcap FundPublic Shareholding2.9%48,11,091
Axis Mutual Fund Trustee Limited A/c Axis Mutual Fund A/c Axis Small Cap FundPublic Shareholding2.5%41,38,847
Kotak Midcap FundPublic Shareholding2.4%39,86,904
Dsp Small Cap FundPublic Shareholding1.6%25,97,609
Hdfc Life Insurance Company LimitedPublic Shareholding1.5%24,86,928
Icici Prudential India Opportunities FundPublic Shareholding1.4%23,33,002
Government Pension Fund GlobalPublic Shareholding1.3%21,69,982
Uti-flexi Cap FundPublic Shareholding1.2%20,36,525
Canara Robeco Mutual Fund A/c Canara Robeco Small Cap FundPublic Shareholding1.1%17,56,065
Ample Up LimitedShareholding of Promoter and Promoter Group0%10
Fosun Industrial Co LimitedShareholding of Promoter and Promoter Group0%10
Lustrous Star LimitedShareholding of Promoter and Promoter Group0%10
Regal Gesture LimitedShareholding of Promoter and Promoter Group0%10
Board of Directors
NameDesignationYear
SRINIVAS SADUChairman / Executive Director / WTD2026
Jia Ai (Allen) ZhangNon-Exec & Non-Independent Dir2026
Wei HuangNon-Exec & Non-Independent Dir2026
UDO JAHANNES VETTERIndependent Non Exe. Director2026
ESSAJI GOOLAM VAHANVATIIndependent Non Exe. Director2026
Naina Lal KidwaiIndependent Non Exe. Director2026
SAMPATH KUMAR PALLERLAMUDICS / Compliance Officer / Vice President2026
Xingli WangAdditional Director2026
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr—
Segments — Geography
RegionRevenueShare
USA₹2,128 Cr61.5%
India₹556 Cr16.1%
Europe₹151 Cr4.4%
Canada₹66 Cr1.9%
Australia₹16 Cr0.5%
Rest Of The World₹546 Cr15.8%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1501616
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-11Dividend (20/- per share)Final
dividend2026-08-11₹20 (2000%)Final
forthcoming2026-08-10Board Meetings—
dividend2025-08-14₹18 (1800%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20261,118004601,163
20265030000503
202611500460161
Insider / Designated-Person Trades

12 recent disclosure(s)

Jayatheerth AdvaniDisposal · 1,000
K RAGHURAMACHANDRA RAODisposal · 1,000
K RAGHURAMACHANDRA RAODisposal · 1,000
Jayatheerth AdvaniDisposal · 500
SREENIVASA RAO SURAGAMDisposal · 500
SREENIVASA RAO SURAGAMDisposal · 1,000
Substantial Acquisitions (SAST)

2 disclosure(s)

Market28/09/2026 · 57,842
Market13/07/2026 · 3,00,972
Company Information
Incorporated1978
ChairmanSRINIVAS SADU
AuditorDeloitte Haskins & Sells
Investor Email[email protected]
🌐 www.glandpharma.com ↗

📍 Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal, Hyderabad, Telangana, 500043

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Giriraj Civil Developers Ltd.Grover Jewells LimitedGKB Ophthalmics Ltd.GK Energy LimitedGujarat Kidney & Super Speciality Ltd.GKW LimitedGlass Wall Systems (India) Ltd.Glaxosmithkline Pharmaceuticals Ltd.Glenmark Pharmaceuticals Ltd.Gujarat Lease Financing LimitedGlobal Education LimitedGlobale Tessile LimitedAll “G” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search